DYN logo

Dyne Therapeutics, Inc. (DYN) Cash and Cash Equivalents

Annual Cash & Cash Equivalents:

$435.45M+$313.82M(+258.02%)
December 31, 2024

Summary

  • As of today, DYN annual cash & cash equivalents is $435.45 million, with the most recent change of +$313.82 million (+258.02%) on December 31, 2024.
  • During the last 3 years, DYN annual cash & cash equivalents has risen by +$234.62 million (+116.83%).
  • DYN annual cash & cash equivalents is now at all-time high.

Performance

DYN Cash and Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

Quarterly Cash & Cash Equivalents:

$791.89M+$107.96M(+15.79%)
September 30, 2025

Summary

  • As of today, DYN quarterly cash & cash equivalents is $791.89 million, with the most recent change of +$107.96 million (+15.79%) on September 30, 2025.
  • Over the past year, DYN quarterly cash & cash equivalents has increased by +$68.21 million (+9.43%).
  • DYN quarterly cash & cash equivalents is now at all-time high.

Performance

DYN Quarterly Cash & Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

DYN Cash and Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+258.0%+9.4%
3Y3 Years+116.8%+219.1%
5Y5 Years+2876.0%+108.6%

DYN Cash and Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+258.0%at high+543.3%
5Y5-Yearat high+2876.0%at high+543.3%
All-TimeAll-Timeat high+5260.0%at high+5312.0%

DYN Cash and Cash Equivalents History

DateAnnualQuarterly
Sep 2025
-
$791.89M(+15.8%)
Jun 2025
-
$683.92M(+0.9%)
Mar 2025
-
$677.49M(+5.5%)
Dec 2024
$435.45M(+258.0%)
$642.27M(-11.2%)
Sep 2024
-
$723.67M(-7.1%)
Jun 2024
-
$778.84M(+71.7%)
Mar 2024
-
$453.55M(+268.4%)
Dec 2023
$121.63M(-29.3%)
$123.10M(-22.0%)
Sep 2023
-
$157.82M(-24.0%)
Jun 2023
-
$207.73M(-12.8%)
Mar 2023
-
$238.21M(-7.0%)
DateAnnualQuarterly
Dec 2022
$172.15M(-14.3%)
$256.01M(+3.2%)
Sep 2022
-
$248.14M(-15.0%)
Jun 2022
-
$291.84M(-9.7%)
Mar 2022
-
$323.15M(-14.2%)
Dec 2021
$200.82M(-33.2%)
$376.57M(-7.6%)
Sep 2021
-
$407.52M(-6.4%)
Jun 2021
-
$435.59M(-9.8%)
Mar 2021
-
$483.08M(+39.9%)
Dec 2020
$300.85M(+1956.1%)
$345.31M(-9.0%)
Sep 2020
-
$379.61M(+2494.4%)
Dec 2019
$14.63M(+80.1%)
$14.63M
Dec 2018
$8.12M
-

FAQ

  • What is Dyne Therapeutics, Inc. annual cash & cash equivalents?
  • What is the all-time high annual cash & cash equivalents for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
  • What is Dyne Therapeutics, Inc. quarterly cash & cash equivalents?
  • What is the all-time high quarterly cash & cash equivalents for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?

What is Dyne Therapeutics, Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of DYN is $435.45M

What is the all-time high annual cash & cash equivalents for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high annual cash & cash equivalents is $435.45M

What is Dyne Therapeutics, Inc. annual cash & cash equivalents year-on-year change?

Over the past year, DYN annual cash & cash equivalents has changed by +$313.82M (+258.02%)

What is Dyne Therapeutics, Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of DYN is $791.89M

What is the all-time high quarterly cash & cash equivalents for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $791.89M

What is Dyne Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, DYN quarterly cash & cash equivalents has changed by +$68.21M (+9.43%)
On this page